ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AKR Acadia Realty Trust

17.01
0.31 (1.86%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,486,787
Bid Price
Ask Price
News -
Day High 17.04

Low
12.37

52 Week Range

High
17.728

Day Low 16.79
Company Name Stock Ticker Symbol Market Type
Acadia Realty Trust AKR NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.31 1.86% 17.01 20:00:00
Open Price Low Price High Price Close Price Prev Close
16.79 16.79 17.04 17.01 16.70
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,118 1,486,787 $ 16.88 $ 25,094,505 - 12.37 - 17.728
Last Trade Time Type Quantity Stock Price Currency
19:00:00 557,259 $ 17.01 USD

Acadia Realty Trust Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.75B 102.58M - 338.69M 19.87M 0.19 87.87
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Acadia Realty News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AKR Message Board. Create One! See More Posts on AKR Message Board See More Message Board Posts

Historical AKR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week16.7717.16516.128316.58877,0250.241.43%
1 Month16.7917.16516.09516.481,164,4080.221.31%
3 Months16.7417.72816.09516.831,193,5660.271.61%
6 Months14.3617.72813.2416.09976,0052.6518.45%
1 Year13.2817.72812.3715.36870,7403.7328.09%
3 Years19.4723.3312.2817.21714,355-2.46-12.63%
5 Years27.2629.54969.1017.60702,636-10.25-37.60%

Acadia Realty Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Your Recent History

Delayed Upgrade Clock